News

National Institute for Clinical Excellence NICE

Cost regulators for the National Health Service in England and Wales are sticking with their initial decision to reject the use of GlaskoSmithKline's

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. By - Prof Michael Untch MD, Sibylle Loibl MD,...

Cut the Pink Ties to the Komen Foundation | PRLog

Cut the Pink Ties to the Komen Foundation. Susan G. Komen would roll over in her grave if she knew her name was being used to extort money from women, and then women were being denied the screenings that would prevent them from dying of the same cancer that she died from. - PR11790685

Cancer Stem Cell Therapeutics In Focus - Seeking Alpha

< strong > By < a href='http://www.andrewnorrisonline.com/' > Andrew J. Norris < /a > : < /strong > < p > Emerging evidence continues to reveal the critical nature of cancer stem cells (CSCs) as an essential target in the future of oncology drug development. In a recent study directed by Max S.

Pediatric Epilepsy Center Coordinator Diana Pillas Loses Breast Cancer Battle - 02/08/2010

Diana Pillas, longtime coordinator-counselor of the Pediatric Epilepsy Center at Johns Hopkins Children's Center, died Saturday, Feb. 6, of breast cancer. Pillas, 69, continued to work until the week before her death.

Body By Leverett Launches 2012 Breast Cancer Fundraising Campaign

Dr. Larry Leverett, a renowned cosmetic surgeon in Phoenix, launches a fundraising campaign to support breast cancer charities.

amednews: Breast cancer risk can be reduced through lifestyle changes :: Dec. 19, 2011 ... American

Avoiding unnecessary medical radiation and tobacco smoke and exercising regularly might lower women's chances of contracting the disease, a new IOM report says.

FDA Removes Avastin Breast Cancer Indication - Pharmaceutical Technology

The breast cancer indication for Avastin has been revoked after FDA Commissioner Margaret A. Hamburg concluded that the drug has not been shown to be safe and effective for this use.

Michelle’s Place Breast Cancer Resource Center Celebrates 10 Years of Service with Endowment

Michelle’s Place Breast Cancer Resource Center is celebrating 10 years of service this month. Since its inception, Michelle’s Place has provided over 60,000 services to Temecula Valley. To mark this milestone the non-profit is starting The Michelle’s Place Endowment to ensure the organization will

Older women missing out on breast cancer treatment | 6minutes

Major declines in breast cancer death rates since the 1990s have been confined to women under 75, research shows.

Results 1-10 of 2,859
 


Refine by Content Type:

  • Refined by: News  


Refine by Source:

50 Sources ...